Browsing Category

Press Release

62735 posts
Azentio Software wins double honours at IBSi Global FinTech Innovation Awards 2023

Azentio Software wins double honours at IBSi Global FinTech Innovation Awards 2023

Awards recognize ‘Impact-Generating Implementations’ at Summit Bank, Pakistan and Vision Bank, UAE…
citizenM Menlo Park Hotel Jointly Built by CIMC Group Officially Opened in Silicon Valley, USA

citizenM Menlo Park Hotel Jointly Built by CIMC Group Officially Opened in Silicon Valley, USA

SHENZHEN, China, Dec. 10, 2023 /PRNewswire/ — Recently, the iconic citizenM Menlo Park…
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK),…
CM Energy Led Consortium Won US3.8 Million Order for Oil Rig Moderation and O&M Services in Mexico

CM Energy Led Consortium Won US$163.8 Million Order for Oil Rig Moderation and O&M Services in Mexico

HONGKONG  , Dec. 11, 2023 /PRNewswire/ — On December 11, 2023, TSC Manufacturing…
CREAL announces the launch of its Singapore office to accelerate its Japanese real estate offering to investors in Singapore.

CREAL announces the launch of its Singapore office to accelerate its Japanese real estate offering to investors in Singapore.

SINGAPORE, Dec. 11, 2023 /PRNewswire/ — CREAL Inc, a leading Japanese real…
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ — Ascentage Pharma…
Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR

Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR

SUZHOU, China and ROCKVILLE, Md., Dec. 11, 2023 /PRNewswire/ — Ascentage Pharma…
DHGATE Group Co-CEO Chun Li, Addresses the 2023 GoGlobal Forum of 100, Advocates for Enhanced Services to Uplift Global Small Businesses

DHGATE Group Co-CEO Chun Li, Addresses the 2023 GoGlobal Forum of 100, Advocates for Enhanced Services to Uplift Global Small Businesses

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — DHGATE Group, China’s leading B2B cross-border…